Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2007-05-01
2007-05-01
Navarro, Mark (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C424S184100, C424S185100, C435S007100, C530S380000, C530S381000
Reexamination Certificate
active
09674254
ABSTRACT:
Methods and reagents for the diagnosis of female infertility, prognostic indicators for female infertility, compounds for the treatment of female infertility, compounds and methods for contraception. Methods and compounds are based on the levels of ebaf in endometrial tissue. Methods for diagnosing endometrial receptivity and bleeding function by screening a biological sample such as an endometrial tissue sample, or bodily fluid for the presence of ebaf. A contraceptive compound containing an effective amount of ebaf and a pharmaceutically acceptable carrier. A diagnostic kit for timing contraception containing reagents for screening a sample for the presence of ebaf. A method of treating endometrial irregularities by down-regulating the expression of ebaf.
REFERENCES:
patent: 4444879 (1984-04-01), Foster et al.
patent: 5286624 (1994-02-01), Terashima et al.
patent: 5395825 (1995-03-01), Feinberg et al.
patent: 5420016 (1995-05-01), Boguslaski et al.
patent: 5554339 (1996-09-01), Cozzette et al.
patent: 5616561 (1997-04-01), Barcellos-Hoff
patent: 5693479 (1997-12-01), Feinberg et al.
patent: 5709837 (1998-01-01), Mori et al.
patent: 5874479 (1999-02-01), Martin
patent: 5916751 (1999-06-01), Tabibzadeh et al.
patent: 6027917 (2000-02-01), Celeste et al.
patent: 6040431 (2000-03-01), Keck et al.
patent: 6242568 (2001-06-01), Barbas et al.
patent: 6294662 (2001-09-01), Tabibzadeh
patent: 6428966 (2002-08-01), Lee et al.
patent: 6492497 (2002-12-01), Thompson et al.
patent: 6635480 (2003-10-01), Lee et al.
patent: 6649588 (2003-11-01), Tabibzadeh et al.
patent: 6677432 (2004-01-01), Oppermann et al.
patent: 6683156 (2004-01-01), Tabibzadeh
patent: 6747004 (2004-06-01), Tabibzadeh
patent: 2003/0022841 (2003-01-01), Lee et al.
patent: 2003/0032047 (2003-02-01), Tabibzadeh
patent: 2003/0064069 (2003-04-01), Thompson et al.
patent: 2003/0091566 (2003-05-01), Thompson et al.
patent: 2005/0276802 (2005-12-01), Adams et al.
patent: WO 99/06443 (1999-02-01), None
patent: WO 99/06444 (1999-02-01), None
patent: WO 99/55902 (1999-11-01), None
patent: WO 01/01134 (2001-01-01), None
Kothapalli, Ravi et al, Journal of Clinical Investigation, vol. 99, No. 10, pp. 2342-2350, May 1997.
Kothapalli, Ravi et al, J. Clinical Investigation, Voo. 99(10), May 1997, pp. 2342-2350.
Leonard, SN et al, Transforming growth factor beta 1 expression in the endometrium of the mare during placentation.Molecular Reproduction and Development, vol. 42, 131-140, 1995.
Wieczorek, Z et al, International Journal of Peptide and protein research, vol. 46, pp. 113-118, Jul. 1995, The immunomodulatory diversity of the proteins of the transforming growth B (TGFB) family.
Meno, Chikara et al, Left-right asymmetric expredssion of the TGFB-family member lefty in mouse embryos, Nature vol. 381, May 9, 1996.
Burt, DW et al, Biochemical and biophysical research communications, Sep. 30, 1992, vol. 187(3), pp. 1298-1305, Multiple growth factor mRNAs are expressed in chicken adipocyte precursor cells.
Bowie, James U et al, Deciperhing the Message in Protein Sequences:Tolerance to amino acid substitution, Science Mar. 16, 1990, vol. 247, pp. 1306-1310.
Bassi et al, accession Nos. AF081508; AF081510; AF081509.
Meno et al, Nature 1996, reference of record,151-155.
Sporn, MB et al, The American Society of Cell Biology, Cell Regulation, vol. pp. 875-882; Nov. 1990.
Kothapalli et al, J. Clin. Invest. vol. 99, No. 10, May 1997, pp. 2342-2350.
Tabibzadeh, S et al, Molecular Human Reproduction, vol. 4(6), pp. 595-602, 1998.
Roberts, AB et al, Phil. Trans. R. Soc. Lond. B, vol. 327, pp. 145-154, 1990.
Burt, David W. et al, Molecular Endocrinology, vol. 6(6), pp. 989-992.
Flanders, Kathleen C. et al, Biochemistry, 1988, vol. 27, pates 739-746, Antibodies to peptide determinants in Transforming Growth Factor B and their Applications.
Postlethwaite, AE et al, Journal of Cellular Physiology, vol. 164, pp. 587-592, 1995.
Teicher, BA et al, 1996, Cancer Chemther. Pharmacol., vol. 37, pp. 601-609.
Newcom, Samuel R et al, Blood, vol. 75(12), Jun. 15, 1990, pp. 2434-2437.
Dillner, J et al, PNAS, vol. 81, 4652-4656, Aug. 1984, antibodies against a synthetic peptide (Gly-Ala).
Oosterlynck, DJ et al, vol. 83(2), Feb. 1994, pp. 287-292 Transforming growth factor B activity is increased in peritoneal fluid from women with endometriosis.
Ayala, A et al, Immunology, vol. 79, pp. 479-484, 1993, The release of transforming growth factor B following haemorrhage: its role as a mediator for host immunosuppression.
Hoefer, M et al, Cancer Immunol. Immunother. 1995, pp. 302-308, vol. 41, Anti(transforming growth factor B ) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu
u mice.
RNA Image Kit Product Brochure, 1993, pp. 1-21.
“DNA Sequencing by the Dideoxy Method,” Sequences Ver. 2.0 A New Genetically Engineered Enzyme for DNA Sequencing, U.S. Biochemical Corp., 1988-89, pp. 7-29-7-35.
Analysis of RNA by Northern and Slot Blot Hybridization, Current Protocols in Molecular Biology, Unit 4.9, 1993, pp. 4.9.1-4.9.14.
Hillier et al. Genbank Accession No. R37562, May 1995.
Frigerio et al. Genbank Accession No. T25016, May 1995.
Liang et al. “Differential Display Using One-Base Anchored Oligo-dT Primers”Nucleic Acids Research, 1994, pp. 5763-5764, vol. 22, No. 25.
Tabibzadeh et al. “Distinct Tumor Specific Expression of TGFB4 (ebaf), a Novel Human Gene of the TGF-B Superfamily”Frontiers in Bioscience 2, Jul. 1997, pp. 18-25.
Tabibzadeh et al. “Dysregulated Expression of ebaf, a Novel Molecular Defect in the Endometria of Patients with Infertility”The Journal of Clinical Endocrinology&Metabolism, Mar. 8, 2000, pp. 2526-2536, vol. 85, No. 7.
Tabibzadeh et al. “Temporal and Site-Specific Expression of Transforming Growth Factor-β4 in Human Endometrium”Molecular Human Reproduction, 1998, pp. 595-602, vol. 4, No. 6.
Navarro Mark
Portner Ginny Allen
Saliwanchik Lloyd & Saliwanchik
University of South Florida
LandOfFree
Diagnostic markers of human female infertility does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic markers of human female infertility, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic markers of human female infertility will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3729974